- Home
- FSTR vs TLSI Comparison
FSTR vs TLSI Comparison
Compare FSTR & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- TLSI
- Stock Information
- Founded
- FSTR 1902
- TLSI 2010
- Country
- FSTR United States
- TLSI United States
- Employees
- FSTR N/A
- TLSI N/A
- Industry
- FSTR Metal Fabrications
- TLSI Medical Specialities
- Sector
- FSTR Industrials
- TLSI Health Care
- Exchange
- FSTR Nasdaq
- TLSI Nasdaq
- Market Cap
- FSTR 285.6M
- TLSI 244.3M
- IPO Year
- FSTR N/A
- TLSI N/A
- Fundamental
- Price
- FSTR $25.90
- TLSI $4.73
- Analyst Decision
- FSTR Hold
- TLSI Strong Buy
- Analyst Count
- FSTR 1
- TLSI 4
- Target Price
- FSTR $25.00
- TLSI $11.13
- AVG Volume (30 Days)
- FSTR 27.3K
- TLSI 118.6K
- Earning Date
- FSTR 11-06-2025
- TLSI 11-13-2025
- Dividend Yield
- FSTR N/A
- TLSI N/A
- EPS Growth
- FSTR 395.33
- TLSI N/A
- EPS
- FSTR 3.32
- TLSI N/A
- Revenue
- FSTR $506,999,000.00
- TLSI $35,990,000.00
- Revenue This Year
- FSTR $3.93
- TLSI $56.79
- Revenue Next Year
- FSTR $4.51
- TLSI $54.15
- P/E Ratio
- FSTR $7.80
- TLSI N/A
- Revenue Growth
- FSTR N/A
- TLSI 45.50
- 52 Week Low
- FSTR $17.16
- TLSI $3.42
- 52 Week High
- FSTR $29.78
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- FSTR 46.48
- TLSI 48.36
- Support Level
- FSTR $26.22
- TLSI $4.42
- Resistance Level
- FSTR $26.90
- TLSI $4.67
- Average True Range (ATR)
- FSTR 0.81
- TLSI 0.23
- MACD
- FSTR -0.25
- TLSI -0.03
- Stochastic Oscillator
- FSTR 4.48
- TLSI 61.87
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.